- Home
- OMI vs SAGE Comparison
OMI vs SAGE Comparison
Compare OMI & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMI
- SAGE
- Stock Information
- Founded
- OMI 1882
- SAGE 2010
- Country
- OMI United States
- SAGE United States
- Employees
- OMI N/A
- SAGE N/A
- Industry
- OMI Medical Specialities
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- OMI Health Care
- SAGE Health Care
- Exchange
- OMI Nasdaq
- SAGE Nasdaq
- Market Cap
- OMI 545.4M
- SAGE 571.7M
- IPO Year
- OMI N/A
- SAGE 2014
- Fundamental
- Price
- OMI $9.46
- SAGE $9.11
- Analyst Decision
- OMI Hold
- SAGE Hold
- Analyst Count
- OMI 6
- SAGE 18
- Target Price
- OMI $12.67
- SAGE $10.06
- AVG Volume (30 Days)
- OMI 1.5M
- SAGE 2.8M
- Earning Date
- OMI 08-01-2025
- SAGE 07-30-2025
- Dividend Yield
- OMI N/A
- SAGE N/A
- EPS Growth
- OMI N/A
- SAGE N/A
- EPS
- OMI N/A
- SAGE N/A
- Revenue
- OMI $10,720,251,000.00
- SAGE $47,404,000.00
- Revenue This Year
- OMI $3.66
- SAGE $102.21
- Revenue Next Year
- OMI $2.52
- SAGE $43.01
- P/E Ratio
- OMI N/A
- SAGE N/A
- Revenue Growth
- OMI 2.84
- SAGE N/A
- 52 Week Low
- OMI $6.07
- SAGE $4.62
- 52 Week High
- OMI $16.98
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- OMI 68.48
- SAGE 72.61
- Support Level
- OMI $7.03
- SAGE $9.04
- Resistance Level
- OMI $9.14
- SAGE $9.30
- Average True Range (ATR)
- OMI 0.42
- SAGE 0.18
- MACD
- OMI 0.16
- SAGE 0.09
- Stochastic Oscillator
- OMI 92.89
- SAGE 92.56
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.